✦ LIBER ✦

Clinically Insignificant Negative Interferences of Spironolactone, Potassium Canrenoate, and Their Common Metabolite Canrenone in New Dimension Vista LOCI Digoxin Immunoassay

✍ Scribed by Amitava Dasgupta; Myrtle J. Johnson; Tamal K. Sengupta

Book ID: 112120522
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 498 KB
Volume: 26
Category: Article
ISSN: 0887-8013
DOI: 10.1002/jcla.21501

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of spironolactone, potassium canr

Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on dimension Vista Digoxin Assay

✍ Amitava Dasgupta; Myrtle J. Johnson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract Spironolactone, a potassium sparing diuretic metabolized to canrenone, is often used with digoxin to treat various conditions including congestive heart failure. Potassium canrenoate is a similar drug that is also metabolized to canrenone. Due to reported interference of spironolactone,

A new enzyme-linked chemiluminescent imm

A new enzyme-linked chemiluminescent immunosorbent digoxin assay is virtually free from interference of spironolactone, potassium canrenoate, and their common metabolite canrenone

✍ Amitava Dasgupta; Edward Kang; Pradip Datta 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract Spironolactone and potassium canrenoate (aldosterone antagonist diuretics) are sometimes used in conjunction with digoxin for patient management. Spironolactone, potassium canrenoate, and their common metabolite canrenone interfere with serum digoxin measurement using various immunoassa